SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis.

Khan, AR; Riaz, M; Bin Abdulhak, AA; Al-Tannir, MA; Garbati, MA; Erwin, PJ; Baddour, LM; Tleyjeh, IM (2013) The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One, 8 (1). ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0052929
SGUL Authors: Riaz, Muhammad

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (577kB) | Preview

Abstract

BACKGROUND: Emerging epidemiological evidence suggests that statins may reduce the risk of community-acquired pneumonia (CAP) and its complications. PURPOSE: Performed a systematic review to address the role of statins in the prevention or treatment of CAP. DATA SOURCE: Ovid MEDLINE, Cochrane, EMBASE, ISI Web of Science, and Scopus from inception through December 2011 were searched for randomized clinical trials, cohort and case-control studies. STUDY SELECTION: Two authors independently reviewed studies that examined the role of statins in CAP. DATA EXTRACTION: Data about study characteristics, adjusted effect-estimates and quality characteristics was extracted. DATA SYNTHESIS: Eighteen studies corresponding to 21 effect-estimates (eight and 13 of which addressed the preventive and therapeutic roles of statins, respectively) were included. All studies were of good methodological quality. Random-effects meta-analyses of adjusted effect-estimates were used. Statins were associated with a lower risk of CAP, 0.84 (95% CI, 0.74-0.95), I(2) = 90.5% and a lower short-term mortality in patients with CAP, 0.68 (95% CI, 0.59-0.78), I(2) = 75.7%. Meta-regression did not identify sources of heterogeneity. A funnel plot suggested publication bias in the treatment group, which was adjusted by a novel regression method with a resultant effect-estimate of 0.85 (95% CI, 0.77-0.93). Sensitivity analyses using the rule-out approach showed that it is unlikely that the results were due to an unmeasured confounder. CONCLUSIONS: Our meta-analysis reveals a beneficial role of statins for the risk of development and mortality associated with CAP. However, the results constitute very low quality evidence as per the GRADE framework due to observational study design, heterogeneity and publication bias.

Item Type: Article
Additional Information: © 2013 Khan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Community-Acquired Infections, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pneumonia, General Science & Technology, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: PLoS One
Article Number: e52929
ISSN: 1932-6203
Language: eng
Dates:
DateEvent
7 January 2013Published
PubMed ID: 23349694
Web of Science ID: 23349694
Download EPMC Full text (HTML)
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/105153
Publisher's version: https://doi.org/10.1371/journal.pone.0052929

Actions (login required)

Edit Item Edit Item